Professional Documents
Culture Documents
Author Manuscript
Hypertension. Author manuscript; available in PMC 2009 November 1.
Published in final edited form as:
NIH-PA Author Manuscript
Qi Fu, MD, PhD1,2, Wanpen Vongpatanasin, MD2, and Benjamin D. Levine, MD1,2
1Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas
Introduction
Blood pressure (BP) increases with advancing age in humans in most industrialized societies.
NIH-PA Author Manuscript
The relationship between systolic and diastolic pressures to cardiovascular events is generally
more pronounced in people aged ≥65 years.1 The Framingham Heart Study and the National
Health and Nutrition Examination Survey uniformly demonstrated a higher prevalence of
hypertension and a lower BP control rate in elderly women than men.2, 3 Specifically, only
23-28% of hypertensive women over the age of 60 achieved BP goals on treatment, whereas
36-38% of hypertensive men of the same age reached the target BP.2 Precise mechanisms for
this observation are unknown, but may be related to sex differences in the pathophysiology of
hypertension or responses to antihypertensive therapy.
It has been recognized that the pathophysiology of hypertension in the elderly is largely due
to an age-related decline in aortic distensibility resulting in progressive increases in systolic
pressure and pulse pressure and a decrease in diastolic pressure.4, 5 However, large
epidemiological studies have shown that not only systolic but also diastolic pressure is higher
in elderly women than men, suggesting that other mechanism(s) may contribute to sex
differences in BP regulation. For example, one recent study demonstrated that aging was
accompanied by a greater increase in sympathetic traffic in healthy women than men.6 It is
well known that elevated sympathetic activity plays an important role in the development of
hypertension in the young and middle-aged population.7-10 Whether a sympathetic neural
NIH-PA Author Manuscript
mechanism is responsible for the high prevalence of hypertension and the poor BP control rate
in elderly women remains unclear. Additionally, whether ventricular-arterial function and
some hormonal markers are non-neural differences that may also contribute to the influence
of aging on BP control in elderly women needs to be verified.
Corresponding author: Benjamin D. Levine, MD, Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas,
7232 Greenville Avenue, Suite 435, Dallas, Texas 75231, Phone: (214) 345-4620, Fax: (214) 345-4618, Email: E-mail:
BenjaminLevine@TexasHealth.org.
DISCLOSURES
None.
Fu et al. Page 2
regarded as an effective therapy for elderly hypertensive patients compared with standard
pharmacologic therapies.
In this review, we highlight some previous results of neural and non-neural control in elderly
hypertensives as well as exercise training as a non-drug antihypertensive therapy in this
particularly challenging patient population. An overview of neural and non-neural
mechanisms, and the possible role of exercise training is depicted in Figure 1. The techniques
used in previous studies to assess neural and non-neural control in hypertensive patients are
summarized in Table 1.
Laitinen et al19 showed that during upright posture, the increase in heart rate was more
pronounced in young individuals, whereas the increase in peripheral vascular resistance was
more dramatic in the elderly, suggesting that vascular responses related to vasoactive
mechanisms and vasomotor sympathetic regulation become augmented with increasing age.
Although the study by Laitinen et al19 focused on age but not sex, it seems likely that
augmented sympathetic vasoconstriction plays a more critical role in elderly hypertensive
women. Indeed, this notion was supported by the findings of Lipsitz et al,20 showing enhanced
vasoreactivity in elderly hypertensive women. They found that elderly hypertensive women
had a much greater increase in systemic vascular resistance than elderly hypertensive men
during upright tilt, which was associated with a greater low-frequency systolic pressure
variability, a presumed marker of sympathetic vascular control.20 Since muscle sympathetic
nerve activity was not measured in this study, it is difficult to be certain whether the enhanced
vascular resistance response was due to an increase in sympathetic outflow in these patients.
21 It was shown that alpha-adrenergic vasoconstriction was blunted despite elevated
sympathetic activity in the peripheral22 and renal arteries in healthy elderly men.23
NIH-PA Author Manuscript
Mechanisms underlying this observation is unknown, but a recent study in rats indicates that
aging is associated with a decline in alpha adrenergic-receptor expression and binding affinity
in male rats, but not in female rats.24 Therefore, a sex-specific, age-related difference in alpha-
adrenergic vasoconstriction may also contribute to the enhanced vasoreactivity in elderly
hypertensive women.
Previous studies have suggested that hypertension is associated with a resetting of the
cardiovagal baroreflex arc at a higher set point.25 With the spectral transfer function analysis
technique, it was found that the sensitivity of baroreflex control of heart rate did not differ
between normotensive men and women,26, 27 but hypertensive patients had lower baroreflex
sensitivity than normotensive controls; moreover, cardiovagal baroreflex sensitivity was
significantly reduced in middle-aged hypertensive women compared with age-matched
hypertensive men.27 It was proposed that sex was an important determinant of the cardiovagal
stiffness and early pulse wave reflection) predominated over increased vascular resistance in
these elderly patients.4, 37 Age and hypertension are associated with alterations in the elastic
properties of the arterial wall that cause profound changes in arterial pressure waves, while
these changes are attributed primarily to the changes in amplitude and timing of pulse wave
reflections from peripheral reflecting sites in the lower body.38
There is increasing evidence to support the concept that the age-related increase in aortic
stiffness is significantly greater in women than men (Figure 3).39 A recent study by Berry et
al40 found that elderly systolic hypertensive women had stiffer large arteries, greater central
wave reflection, and higher pulse pressure than elderly hypertensive men, and they thereby
concluded that stiffer large arteries likely contributed to the greater prevalence of systolic
hypertension in elderly women and may partly explain the acceleration in postmenopausal
cerebrovascular and cardiac complications. However, the Third National Health and Nutrition
Examination Survey showed that not only systolic but also diastolic pressure was higher in
elderly women compared with elderly men.41 Whether the greater prevalence of diastolic
hypertension and/or combined systolic-diastolic hypertension in elderly women can also be
explained by impaired ventricular-arterial function alone or whether other mechanisms play
an additional role remains unclear.
NIH-PA Author Manuscript
It has been shown that menopause is associated with increased susceptibility to salt-induced
rise in BP.42, 43 Schulman et al44 demonstrated that salt sensitivity of BP increased
significantly 4 months after surgical menopause in middle-aged women, which could be related
to increased angiotensin receptor subtype 1 expression in the kidney.45 Salt-sensitive
hypertensive patients have a higher incidence of left ventricular hypertrophy,46, 47, endothelial
dysfunction,48, insulin resistance,49 and hyperlipidemia50 compared with salt-resistant
hypertensive patients. Thus decreases in sex hormones and increased sensitivity to sodium may
be important factors in the genesis of postmenopausal hyperteniosn.51
Aging generally leads to reductions in physical activity in both humans and animals. A
sedentary lifestyle increases the risk of hypertension, while increased physical activity or
exercise training is associated with lower levels of BP.52, 53 We found that a sedentary lifestyle
during normal aging led to cardiac atrophy and an increase in arterial elastance/stiffness, while
very prolonged exercise training prevented ventricular-arterial stiffening (Figure 4).54
Recently, we demonstrated that three to six months of endurance training in initially sedentary
seniors reduced both systolic and diastolic pressures effectively.55 Training-induced reduction
in BP has been proposed to be associated with an increased release of nitric oxide, resulting
from an increase in vascular shear stress during exercise.56 Chronic increases in shear stresses
lead to function and histological alterations of vascular endothelium, causing enhanced
vascular structure and function.57
Exercise training was found to improve arterial compliance in healthy middle-aged individuals,
58 but it was reported that short-term (i.e., 8 weeks) training did not modify large-artery
compliance and left ventricular mass or function in elderly patients with isolated systolic
hypertension.59 However, one recent study showed that although arterial compliance remained
unchanged, flow-mediated endothelium-dependent vasodilation increased after 12 weeks of
training in elderly hypertensives, indicating improved endothelial function.60 Rinder et al61
NIH-PA Author Manuscript
found that long-term (i.e., 6 months) training not only decreased BP but also induced regression
of left ventricular hypertrophy in elderly hypertensive patients. Recently, Westhoff et al62
demonstrated in elderly hypertensives that 12 weeks of training evoked comparable reductions
in BP and improvements of endothelial function in the presence and absence of beta-blockades,
suggesting that drug therapy provided no additive benefit to and did not prevent the
antihypertensive effects of exercise training. These results are consistent with some previous
reports with both selective and non-selective beta-blockade as well as calcium-channel
blockers.63-68
Grassi et al69 showed in young hypertensive men that the BP reduction after training was
mediated by a neural mechanism, since vasomotor sympathetic activity decreased after 10
weeks of training. Similar results were obtained in middle-aged and elderly hypertensives after
4 and 6 months of training,70, 71 indicating that suppression of sympathetic activity may play
a role in the reduction in arterial pressure. Additionally, the sympathetic baroreflex function
was improved after training in middle-aged hypertensive patients.70 Elevated sympathetic
activity was found to be associated with an increase in arterial wall thickening72 and left
ventricular mass.73 Thus, training-induced decreases in sympathetic activity may be beneficial
in preventing arterial stiffening in hypertension.
NIH-PA Author Manuscript
Exercise training could elicit adaptations in the adrenergic system, since the sympathetic
nervous system is activated during each bout of exercise and repeated activation of the
sympathetic nervous system may result in an attenuation of sympathetic activity.74 Animal
studies suggested that nitric oxide decreased overall sympathetic excitability within the
brainstem and possibly through actions in higher brain regions (i.e., hypothalamus).75, 76 Due
to the inevitable experimental restrictions, it is unclear whether the increased release of nitric
oxide during exercise training has a central sympathoinhibitory effect in humans. It is also
unclear whether training reduces salt sensitivity in elderly women. Previous studies
demonstrated that hyperinsulinemia and insulin resistance were associated with hypertension
and sympathetic activation,77, 78 while training could improve insulin sensitivity in
normotensive and hypertensive individuals.79, 80 Training-induced muscle adaptations also
appear to be important in attenuating insulin mediated sympathetic activation. Additionally,
exercise training has been shown to improve aerobic capacity, vascular conductance, and lower
body fat, each of which could also contribute to a reduction in BP.81-85 The improved vascular
conductance in athletes and with training is not endothelial mediated, and probably reflects
structural adaptations required to accommodate a high muscle blood flow.84, 85
NIH-PA Author Manuscript
Significance
It is important to note that approximately two-thirds of elderly hypertensive women, who are
most at risk for stroke and cardiovascular events, do not have their BP adequately controlled,
either because they are not on drug treatment or because in spite of taking antihypertensive
drugs, their BP is still above recommended levels. The questions of which drug classes offer
the most benefit for these patients, whether antihypertensive drug treatment should be the same
or different for elderly men and women, and whether non-pharmacologic therapy, such as
exercise training is effective for elderly hypertensive women are as yet unanswered. If a
heightened level of sympathetic activity coupled with elevated arterial stiffness is the
fundamental mechanism of hypertension in elderly women which cannot be reversed by most
antihypertensive agents, exercise training may be an integral strategy to achieve BP control in
this patient population by reducing both sympathoexcitation and arterial stiffness. If this is the
case, formal exercise training should be incorporated as an essential part of hypertension
treatment in elderly hypertensive women in addition to BP medications.
Acknowledgments
NIH-PA Author Manuscript
SOURCES OF FUNDING
Some of the work included in this review was supported by grants from the National Institutes of Health (AG17479
and HL075283) and the American Heart Association Texas Affiliate Beginning Grant-In-Aid (0060024Y).
REFERENCES
1. National High Blood Pressure Education Program Working Group. National High Blood Pressure
Education Program Working Group Report on Hypertension in the Elderly. Hypertension
1994;23:275–285. [PubMed: 8125550]
2. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes
and control in the community. JAMA 2005;294:466–472. [PubMed: 16046653]
3. Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, Francis J, Grimm R,
Kotchen T, Langer R, Lasser N. Hypertension and its treatment in postmenopausal women: baseline
data from the Women’s Health Initiative. Hypertension 2000;36:780–789. [PubMed: 11082143]
4. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J
Hypertens Suppl 1992;10:S73–77. [PubMed: 1432333]
5. Franklin SS, Gustin Wt, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic
NIH-PA Author Manuscript
patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation
1997;96:308–315. [PubMed: 9236450]
6. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective
interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005;45:522–
525. [PubMed: 15767469]
7. Goldstein DS. Plasma catecholamines and essential hypertension. An analytical review. Hypertension
1983;5:86–99. [PubMed: 6336721]
8. Goldstein DS. Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension
1981;3:48–52. [PubMed: 7203605]
9. Goldstein DS, Lake CR, Chernow B, Ziegler MG, Coleman MD, Taylor AA, Mitchell JR, Kopin IJ,
Keiser HR. Age-dependence of hypertensive-normotensive differences in plasma norepinephrine.
Hypertension 1983;5:100–104. [PubMed: 6848457]
10. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve activity and
neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta
Physiol Scand 2003;177:275–284. [PubMed: 12608997]
11. Ivanovic B, Cumming ME, Pinkham CA. Relationships between treated hypertension and subsequent
mortality in an insured population. J Insur Med 2004;36:16–26. [PubMed: 15104026]
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. Jones DW, Materson
NIH-PA Author Manuscript
BJ, Oparil S, Wright JT Jr. Roccella EJ. Seventh report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension
2003;42:1206–1252. [PubMed: 14656957]
13. Fu Q, Zhang R, Witkowski S, Arbab-Zadeh A, Prasad A, Okazaki K, Levine BD. Persistent
sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term
morbidity? Hypertension 2005;45:513–521. [PubMed: 15738344]
14. Fu Q, Witkowski S, Levine BD. Vasoconstrictor reserve and sympathetic neural control of orthostasis.
Circulation 2004;110:2931–2937. [PubMed: 15505093]
15. Johnson JM, Rowell LB, Niederberger M, Eisman MM. Human splanchnic and forearm
vasoconstrictor responses to reductions of right atrial and aortic pressures. Circ Res 1974;34:515–
524. [PubMed: 4826928]
16. Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest. Relationship to blood
pressure and age. J Physiol 1978;274:621–637. [PubMed: 625012]
17. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and
sympathetic activity in human peripheral nerves. Physiol Rev 1979;59:919–957. [PubMed: 227005]
18. Matsukawa T, Sugiyama Y, Watanabe T, Kobayashi F, Mano T. Gender difference in age-related
changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol 1998;275:R1600–
1604. [PubMed: 9791079]
NIH-PA Author Manuscript
24. Passmore JC, Joshua IG, Rowell PP, Tyagi SC, Falcone JC. Reduced alpha adrenergic mediated
contraction of renal preglomerular blood vessels as a function of gender and aging. J Cell Biochem
2005;96:672–681. [PubMed: 16149078]
NIH-PA Author Manuscript
25. Korner PI, West MJ, Shaw J, Uther JB. “Steady-state” properties of the baroreceptor-heart rate reflex
in essential hypertension in man. Clin Exp Pharmacol Physiol 1974;1:65–76. [PubMed: 4218140]
26. Laitinen T, Hartikainen J, Vanninen E, Niskanen L, Geelen G, Lansimies E. Age and gender
dependency of baroreflex sensitivity in healthy subjects. J Appl Physiol 1998;84:576–583. [PubMed:
9475868]
27. Sevre K, Lefrandt JD, Nordby G, Os I, Mulder M, Gans RO, Rostrup M, Smit AJ. Autonomic function
in hypertensive and normotensive subjects: the importance of gender. Hypertension 2001;37:1351–
1356. [PubMed: 11408376]
28. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der
Kuip DA, Hofman A, Witteman JC. Association between arterial stiffness and atherosclerosis: the
Rotterdam Study. Stroke 2001;32:454–460. [PubMed: 11157182]
29. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness
is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.
Hypertension 2002;39:10–15. [PubMed: 11799071]
30. Glasser SP, Arnett DK, McVeigh GE, Finkelstein SM, Bank AJ, Morgan DJ, Cohn JN. Vascular
compliance and cardiovascular disease: a risk factor or a marker? Am J Hypertens 1997;10:1175–
1189. [PubMed: 9370391]
31. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age- and gender-related
NIH-PA Author Manuscript
44. Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R. Surgical menopause increases
salt sensitivity of blood pressure. Hypertension 2006;47:1168–1174. [PubMed: 16618835]
45. Harrison-Bernard LM, Schulman IH, Raij L. Postovariectomy hypertension is linked to increased
NIH-PA Author Manuscript
renal AT1 receptor and salt sensitivity. Hypertension 2003;42:1157–1163. [PubMed: 14610098]
46. Heimann JC, Drumond S, Alves AT, Barbato AJ, Dichtchekenian V, Marcondes M. Left ventricular
hypertrophy is more marked in salt-sensitive than in salt-resistant hypertensive patients. J Cardiovasc
Pharmacol 1991;17(Suppl 2):S122–124. [PubMed: 1715458]
47. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac
involvement in essential hypertension. Circulation 1988;78:951–956. [PubMed: 2971474]
48. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T. Impairment of endothelial function in salt-
sensitive hypertension in humans. Am J Hypertens 1997;10:1083–1090. [PubMed: 9370377]
49. Suzuki M, Kimura Y, Tsushima M, Harano Y. Association of insulin resistance with salt sensitivity
and nocturnal fall of blood pressure. Hypertension 2000;35:864–868. [PubMed: 10775552]
50. Bigazzi R, Bianchi S, Baldari G, Campese VM. Clustering of cardiovascular risk factors in salt-
sensitive patients with essential hypertension: role of insulin. Am J Hypertens 1996;9:24–32.
[PubMed: 8834703]
51. Tominaga T, Suzuki H, Ogata Y, Matsukawa S, Saruta T. The role of sex hormones and sodium intake
in postmenopausal hypertension. J Hum Hypertens 1991;5:495–500. [PubMed: 1791608]
52. National High Blood Pressure Education Program Working Group report on primary prevention of
hypertension. Arch Intern Med 1993;153:186–208. [PubMed: 8422207]
53. Physical exercise in the management of hypertension: a consensus statement by the World
NIH-PA Author Manuscript
exercise training in elderly subjects treated for isolated systolic hypertension. Kidney Blood Press
Res 2007;30:240–247. [PubMed: 17575470]
61. Rinder MR, Spina RJ, Peterson LR, Koenig CJ, Florence CR, Ehsani AA. Comparison of effects of
exercise and diuretic on left ventricular geometry, mass, and insulin resistance in older hypertensive
adults. Am J Physiol Regul Integr Comp Physiol 2004;287:R360–368. [PubMed: 15117727]
62. Westhoff TH, Franke N, Schmidt S, Vallbracht-Israng K, Zidek W, Dimeo F, van der Giet M. Beta-
blockers do not impair the cardiovascular benefits of endurance training in hypertensives. J Hum
Hypertens 2007;21:486–493. [PubMed: 17330056]
63. Kelemen MH, Effron MB, Valenti SA, Stewart KJ. Exercise training combined with antihypertensive
drug therapy. Effects on lipids, blood pressure, and left ventricular mass. JAMA 1990;263:2766–
2771. [PubMed: 2332919]
64. Radaelli A, Piepoli M, Adamopoulos S, Pipilis A, Clark SJ, Casadei B, Meyer TE, Coats AJ. Effects
of mild physical activity, atenolol and the combination on ambulatory blood pressure in hypertensive
subjects. J Hypertens 1992;10:1279–1282. [PubMed: 1335012]
65. Fagard R, Reybrouck T, Vanhees L, Cattaert A, Vanmeenen T, Grauwels R, Amery A. The effects
of beta blockers on exercise capacity and on training response in elderly subjects. Eur Heart J 1984;5
(Suppl E):117–120. [PubMed: 6526030]
NIH-PA Author Manuscript
66. Duncan JJ, Vaandrager H, Farr JE, Kohl HW, Gordon NF. Effect of intrinsic sympathomimetic
activity on the ability of hypertensive patients to derive a cardiorespiratory training effect during
chronic beta-blockade. Am J Hypertens 1990;3:302–306. [PubMed: 1971751]
67. Ades PA, Gunther PG, Meacham CP, Handy MA, LeWinter MM. Hypertension, exercise, and beta-
adrenergic blockade. Ann Intern Med 1988;109:629–634. [PubMed: 2901818]
68. Ades PA, Gunther PG, Meyer WL, Gibson TC, Maddalena J, Orfeo T. Cardiac and skeletal muscle
adaptations to training in systemic hypertension and effect of beta blockade (metoprolol or
propranolol). Am J Cardiol 1990;66:591–596. [PubMed: 2392980]
69. Grassi G, Seravalle G, Calhoun D, Bolla GB, Mancia G. Physical exercise in essential hypertension.
Chest 1992;101:312S–314S. [PubMed: 1576856]
70. Laterza MC, de Matos LD, Trombetta IC, Braga AM, Roveda F, Alves MJ, Krieger EM, Negrao CE,
Rondon MU. Exercise training restores baroreflex sensitivity in never-treated hypertensive patients.
Hypertension 2007;49:1298–1306. [PubMed: 17438307]
71. Brown MD, Dengel DR, Hogikyan RV, Supiano MA. Sympathetic activity and the heterogenous
blood pressure response to exercise training in hypertensives. J Appl Physiol 2002;92:1434–1442.
[PubMed: 11896007]
72. Dinenno FA, Jones PP, Seals DR, Tanaka H. Age-associated arterial wall thickening is related to
elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol
NIH-PA Author Manuscript
80. Kohno K, Matsuoka H, Takenaka K, Miyake Y, Okuda S, Nomura G, Imaizumi T. Depressor effect
by exercise training is associated with amelioration of hyperinsulinemia and sympathetic
overactivity. Intern Med 2000;39:1013–1019. [PubMed: 11197783]
81. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of hypertension
in healthy normotensive men and women. JAMA 1984;252:487–490. [PubMed: 6737638]
82. Duncan JJ, Farr JE, Upton SJ, Hagan RD, Oglesby ME, Blair SN. The effects of aerobic exercise on
plasma catecholamines and blood pressure in patients with mild essential hypertension. JAMA
1985;254:2609–2613. [PubMed: 4057469]
83. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system.
Am J Hypertens 2001;14:103S–115S. [PubMed: 11411745]
84. Snell PG, Martin WH, Buckey JC, Blomqvist CG. Maximal vascular leg conductance in trained and
untrained men. J Appl Physiol 1987;62:606–610. [PubMed: 3558219]
85. Martin WH 3rd, Montgomery J, Snell PG, Corbett JR, Sokolov JJ, Buckey JC, Maloney DA,
Blomqvist CG. Cardiovascular adaptations to intense swim training in sedentary middle-aged men
and women. Circulation 1987;75:323–330. [PubMed: 3802436]
NIH-PA Author Manuscript
86. Ishikawa K, Ohta T, Zhang J, Hashimoto S, Tanaka H. Influence of age and gender on exercise
training-induced blood pressure reduction in systemic hypertension. Am J Cardiol 1999;84:192–196.
[PubMed: 10426339]
87. Koga M, Ideishi M, Matsusaki M, Tashiro E, Kinoshita A, Ikeda M, Tanaka H, Shindo M, Arakawa
K. Mild exercise decreases plasma endogenous digitalislike substance in hypertensive individuals.
Hypertension 1992;19:II231–236. [PubMed: 1310482]
88. Seals DR, Silverman HG, Reiling MJ, Davy KP. Effect of regular aerobic exercise on elevated blood
pressure in postmenopausal women. Am J Cardiol 1997;80:49–55. [PubMed: 9205019]
89. Esler M, Leonard P, Jackman G, Bobik A, Skews H. Study of noradrenaline uptake and spillover to
plasma in normal subjects and patients with essential hypertension. Prog Biochem Pharmacol
1980;17:75–83. [PubMed: 7208506]
90. Supiano MA, Hogikyan RV, Sidani MA, Galecki AT, Krueger JL. Sympathetic nervous system
activity and alpha-adrenergic responsiveness in older hypertensive humans. Am J Physiol
1999;276:E519–528. [PubMed: 10070019]
91. Turner MJ, Spina RJ, Kohrt WM, Ehsani AA. Effect of endurance exercise training on left ventricular
size and remodeling in older adults with hypertension. J Gerontol A Biol Sci Med Sci 2000;55:M245–
251. [PubMed: 10811155]
92. Kouame N, Nadeau A, Lacourciere Y, Cleroux J. Effects of different training intensities on the
NIH-PA Author Manuscript
Figure 1.
A schematic overview of neural and non-neural mechanisms for sex differences in elderly
hypertension, and the effects of exercise training on hypertension in seniors. Advancing age
and female sex seem to be associated with a marked increase in sympathetic activity and a
dramatic decrease in ventricular-arterial function, both of which may be responsible for the
high prevalence of hypertension in elderly women. Increased sympathetic activity could also
decrease ventricular-arterial function. On the other hand, exercise training increases the release
of nitric oxide through shear stress, which may decrease sympathetic activity and improve
ventricular-arterial function, and therefore, decrease blood pressure in elderly hypertensives.
SNA, sympathetic nerve activity; V-A, ventricular-arterial.
NIH-PA Author Manuscript
Figure 2.
Supine resting muscle sympathetic nerve activity increased with advancing age, and the
increment was greater in women than men. Adapted with permission from Reference 18.
NIH-PA Author Manuscript
Figure 3.
Comparisons of the ventricular-arterial function in men (open circle) and women (filled circle)
in the young, middle-age, and older populations. Data presented as mean±SEM. Significant
difference between sexes within each age group; *P < 0.05, **P < 0.01, ***P < 0.001. Adapted
NIH-PA Author Manuscript
Figure 4.
Effects of normal aging and physical activity on left ventricular mass and arterial elastance in
healthy humans. Derived with permission from Reference 54.
NIH-PA Author Manuscript
Table 1
Techniques used to assess neural and non-neural controls in hypertensive patients
Echocardiography Left ventricular size and geometry and function Rinder et al, 200461
Turner et al, 200091
Acetylene rebreathing technique Arterial afterload Fu et al, 200513
Magnetic resonance imaging Left ventricular size and geometry and function Burns et al, 200773
NIH-PA Author Manuscript
Mechanism Authors, Year, Reference Patients’ Characteristics Measured Variables Training Program Training Effects
Neural Brown et al, 200271 Mild hypertensives (18 NE2 (an index of SNA) Walking/jogging/cycling at 70% of No change in BP
women, 12 men, mean age 63
Fu et al.
Laterza et al, 200770 Mild hypertensives (7 MSNA Cycling at 70% of VO2peak, plus strength Decreased BP
women, 7 men, mean age 44 Sympathetic baroreflex function training, 60 min/time, 3 times/wk for 4 Normalized MSNA
yr) mo Restored baroreflex function
Kouame et al, 199592 Mild to moderate Baroreflex control of limb vascular resistance Cycling at 50% and 70% of VO2peak, 3 Attenuated baroreflex control
hypertensives (1 woman, 8 times/wk, 45 min/time for 10 wk each No change in BP with high
men, mean age 43 yr) intensity training
Kohno et al, 200080 Mild to moderate Baroreflex function (systolic BP and R-R interval Cycling at 75% of VO2peak, 4 times/d, 6 Decreased BP
hypertensives (12 women, 17 relation) min/time for 3 wk Improved baroreflex function
men, mean age 43 yr)
Non-neural Ferrier et al, 200159 Mild isolated systolic Large-artery compliance Cycling at 65% of HRpeak, 3 times/wk, No change in BP
hypertensives (5 women, 5 Left ventricular mass or function 40 min/time for 8 wk No change in arterial
men, mean age 64 yr) mechanical properties or left
ventricular mass and function
Rinder et al, 200461 Mild to moderate Left ventricular geometry and mass and function Walking/jogging/cycling at 60-70% of Decreased BP
hypertensives (3 women, 13 HRpeak, ≥3 times/wk, 40-50 min/time for Regression of left ventricular
men, mean age 66 yr) 6 mo hypertrophy
Westhoff et al, 200762 Mild to moderate Endothelial function assessed by flow-mediated Interval training (treadmill walking, Decreased BP
hypertensives (13 women, 12 dilation with or without beta-blockades), 30-40 Improved endothelial function
men, mean age 68 yr) min/time, 3 times/wk for 12 wk in all patients
Higashi et al, 199993 Mild hypertensives (4 Endothelium-dependent forearm vasorelaxation Brisk walking at 50-60% of VO2peak, 30 Decreased BP
women, 13 men, mean age 47 min/time, 5-7 times/wk for 12 wk Improved endothelium-
yr) dependent vasorelaxation
Turner et al, 200091 Mild to moderate Left ventricular size and geometry and function Walking/jogging/cycling at 60-80% of Decreased BP
hypertensives (2 women, 9 HRpeak, 30-50 min/time, 4 times/wk for Partial regression of left
men, mean age 65 yr) 7 mo ventricle
NE2, extravascular norepinephrine release rate; SNA, sympathetic nerve activity; BP, blood pressure; MSNA, muscle sympathetic nerve activity; VO2peak and HRpeak; peak oxygen uptake and